In supply chain planning, for example, imagine a critical milestone scheduled for June. Typically, teams backtrack from that date to identify key information inputs and decisions needed as early as January or March.

While project management tools provide scheduling functions based on specific dates, the reality is: if these date-based schedules do not evolve into sustained operating frameworks, they are often forgotten and inconsistently reapplied across projects. For instance, a November product launch may backtrack key readiness activities to June, yet without a framework, cross-functional groups may still trigger work too late, risking the milestone. Although organizations conceptually understand time, dates, and durations, we consistently observe a low appreciation of lead times across corporate functions.

The practical evidence is unfortunately clear: teams frequently encounter tight, stressful timelines because the triggers to initiate work were delayed, not because the execution was poor, but because the framework for timely activation was missing.

This lead us to a critical insight: tight timelines often stem from the absence of a standardized timeline framework with predictable, cross-functionally understood triggers as shown in Figure 1 below.

Figure 1: a “T minus” framework mapped to Day 0 (go-live) and aligned with Project Specific Dates. 

Triggers for starting critical activities depend heavily on information availability. However, it is not merely whether information is available — it is whether the certainty of that information is sufficient at the right time. 

Figure 2 illustrates that if a team needs two months to react effectively (Point A), then if information is available only two weeks (Point B) before the milestone, it is inadequate regardless of its accuracy. Thus, the issue is not perfection of information, but sufficiency of reaction time. Information must be shared early enough to allow for necessary actions, even if that information is imperfect. While the tension between accuracy and timing is an age-old challenge without a definitive solution, organizations can significantly mitigate risks by raising awareness and intentionally designing standard frameworks around timing needs. 

To build organizational resilience and predictability, companies must establish timeline guidelines, particularly for high-impact projects like product launches and regulatory filings. These guidelines form the operational backbone for timely execution across functions. One proven structure is the “T minus” framework. In this model, Day 0 represents the go-live date. Activities are scheduled against relative time markers: for instance, T-30 (30 days before), T-60 (60 days before), and so on. This framework detaches planning from calendar-specific dates and shifts the focus to lead times and necessary durations, creating organizational consistency. Refer to Figure 1 again to visualize the “T-minus” mapping.

Instead of saying “Have marketing materials ready by September 15,” the framework would state, “Marketing materials must be ready by T-30,” whatever the launch date is. This reduces confusion across projects and builds repeatable execution muscle. Of course, you will need the September date for project specific alignment, but organizational understanding of the activity as a T-30 day activity enables repeatability and consistency of understanding across projects.

In other words, The T-minus framework does not eliminate the need for project-specific scheduling tools, but it provides a reusable reference architecture that dramatically improves timing predictability. A simple timeline table or Gantt chart structured around T-minus milestones can further clarify deliverable expectations.

Establishing a T-minus timeline framework and embedding it within functional playbooks ensures that the understanding of lead times and critical triggers becomes part of the organization’s operating system, not dependent on individual memory or ad hoc planning. Functional Playbooks should map activities to lead time structures: what must happen at T-120, T-90, T-60, T-30, etc. This approach creates clarity and accountability. Cross-functional launch teams using such Standards and Playbooks at major pharma companies have achieved significant acceleration and/or stayed on timeline despite risks and set backs.

By building these frameworks and playbooks into standard operating practice, organizations can move from reactive firefighting to proactive, scalable execution, while driving better outcomes across product development, supply chain, and regulatory functions. Just like in many other environments, Standards need to be established for the timing and accuracy (or lack thereof) in information sharing. A cross-functional understanding of these standards (i.e. expectations) enables on-time delivery of projects and can even accelerate results.

Wish to discuss more about Advanced Project Management Practices and Playbooks? Schedule a quick connect with Marcos Buelvas here.

Author – Marcos Buelvas, Managing Director, ScaleUp Inc

The post Strengthening Cross-Functional Understanding: A Framework for Timelines Vs. Specific Dates appeared first on ScaleUp Consulting..

In the world of bringing a pharmaceutical product to market, supply chains play a vital and multifaceted role, ensuring the seamless flow of materials, timely delivery of products, and adherence to regulatory requirements across complex global networks. A McKinsey study states, “…On-time delivery generally is not a problem. On-time, in-full (OTIF) fulfillment levels are 97 percent. Clinical drug supply professionals corroborated these findings, as they focus primarily on not missing doses…On the other hand, waste levels for investigational medicinal product (IMP) kits reached a concerning 50 percent, driven primarily by poor forecasting and planning—highlighting a significant opportunity to capture value.” (mckinsey.com).

Just like a Commercial Supply Chain, a Clinical Supply Chain has multiple interconnected nodes and inherent complexity at a global level from the moment the first patient is enrolled. Naturally, the volume of product requirements is relatively low, so the Supply Chain is not yet experiencing high-volume operational constraints and intensive resource requirements. Nevertheless, a continuum of capability building should be present. The reason is simple: there are already escalating costs and potential risks that must be proactively anticipated and mitigated. 

Figure 1 below illustrates the relationship between complexity and time for two variables: The technical readiness of the product itself, as well as its manufacturing, and Supply Chain Maturity. It highlights the interplay between product development and supply chain scalability, emphasizing the challenges and transitions leading to commercial readiness. 

Figure 1. Clinical Supply Chain Complexity vs. Technical and Clinical Uncertainty

The point of the illustration in this figure is to simply acknowledge an evolving landscape across the domains of technical development, clinical uncertainty, and the supply chain’s increasing complexity over time. In many respects, technical and clinical complexity are also increasing, so this is not to suggest otherwise. However, for clinical supply chain purposes, over time, more unknowns are becoming at least directionally better understood and more easily shared by the clinical and technical development groups. For the supply chain, this makes the biggest difference as they are now receiving more robust input to make decisions and establish operational capabilities.

Let’s decompose the Clinical Supply Chain into its parts, see Figure 2 below.

Figure 2. Primary nodes in the End-to-End Clinical Supply Chain

While the 4th segment of the Supply Chain in Figure 2 above is the most visible and widely appreciated outside of the CMC function, a great deal of the supply chain risk lies in nodes 1-3. Commonly, there is a management separation from a Supply Chain point of view at node 3. In other words, nodes 1-3 are managed under one Supply Chain governance, while node 4 is managed under another.

This division makes sense from a workload perspective, but it does create two domains of competency that are not always fully in sync. Let’s discuss improved alignment across these segments.

Achieving Better Clinical & Operations Alignment

An often overlooked, but impactful governance mechanism that can be used to maintain alignment across these functions is a Clinical & Operations Planning (C&OP) process. Typically used for Clinical and CMC alignment, this process actually supports alignment within CMC and outside of it. The key is that cross-functional participation and learning about each function’s key drivers enables streamlined integration of the ever-evolving plans. 

The reality is that Clinical Supply Chain sits in-between to highly variable environments; i.e. CMC development and its inherent variability and clinical operations and its equally variable nature. The position and effective role of the Clinical Supply Chain is illustrated in Figure 3 below. 

Figure 3. Clinical Supply Chain as the link between two evolving functions in the development and clinical trial phases

The role of the Clinical Supply Chain is, therefore, to smooth both sides, de-risk critical connection points, and sustain a stable supply to Clinical Operations. These particular processes closely mirror those linking complex Commercial Supply Chains, offering an opportunity to build capabilities by leveraging ‘light’ Commercial Supply Chain tools and methodologies. These may include Supply Chain Management dashboards, forecast accuracy measurement, performance-to-plan tracking, and others. All of these being core elements of a well functioning C&OP process.

Following this ‘light’ tools approach can significantly enhance a teams’ readiness to support growth, establish risk management processes, and develop future capabilities.

A great example of establishing and operating on-going alignment through C&OP is the Clinical Supply Chain function clearly articulating its information and timing requirements on a recurring basis and through the formal forum of C&OP. A simple diagram of these parts coming together is illustrated in figure 4 below.

Figure 4. The simple elements that are core to a successful C&OP

The formal forum is needed because the clinical supply chain function has to do this in both the CMC and Clin Ops directions since the information needs are to align both.

The processes are ongoing, but there are critical information elements that have critical timing implications. Many of these information elements seem simple to the originator of the information (CMC or Clinical Ops) but they are critical to the clinical supply chain. Things like expected yield, timing of output, and target quantity. From Clin Ops, these may include expected first patient in, dose, and number of patients.

There is always hesitation to provide some of this information given the uncertainty in the processes, and again, this is the case with both CMC and Clinical Ops. This is understandable, but a good rule of thumb is that it may take 12 months for a supply chain to produce and make a product available. While this number can vary, it is helpful to think in this order of magnitude since it is indeed a long time to get a product from beginning to end.

In the world of the Clinical Supply Chain and given these long timeframes, an uncertain number is better than a more accurate one too late in the process. For examples like this, C&OP as a consolidated forum is indeed the best practice as a formal governance process to enable optimized alignment across clinical and supply chain operations.

Wish to discuss more about this subject and how ScaleUp Inc can help you with Clinical & Operations Planning (C&OP) in Clinical Supply Chains? Schedule a quick connect with Marcos Buelvas here.

Author – Marcos Buelvas, Managing Director, ScaleUp Inc

The post Making the Case for Clinical & Operations Planning (C&OP) in Clinical Supply Chains appeared first on ScaleUp Consulting..

Managing the transportation of temperature-controlled products continues to grow increasingly. According to Pharmaceutical Commerce’s annual BioPharma Cold Chain Sourcebook- in 2021 the pharma cold chain logistics is predicted to be $16.6 billion industry. This includes the transport of temperature-controlled goods along a supply chain through refrigerated and thermal packaging procedures and the logistics planning to safeguard the integrity of the shipments.

Understanding the pain points

In the healthcare industry, the pharmaceutical cold chain is a key part of the supply chain and cold chain logistics services help the healthcare and pharmaceutical industry maintain a continuous supply of drugs from distributors and suppliers in various locations.

Nowadays more high-value active ingredients are being used in drug manufacturing that have a short shelf life and come with strict temperature requirements. Hence the need for monitoring and temperature control through the complete supply chain has grown manifolds. Even the drugs that are typically safe at room temperature may need practices to avoid the spikes that come with related transportation.

Logistics providers are now receiving increasing requests for Controlled Room Temperatures which involves the usage of refrigerants, insulated containers, temperature-monitoring electronics, and thermal blanketing. With products being handled multiple times from suppliers to end-user, there is a requirement of an assemblage of temperature controls to maintain quality, coordinated actions, and monitoring tools along the entire supply chain.

The biggest challenge with cold chain logistics is to maintain a certain temperature range throughout the delivery cycle. Multiple variables impact the length of time a product’s temperature is considered controlled. Temperature-controlled transportation requires specialized equipment and trucks, and skilled drivers.

Monitoring the temperature is another huge challenge and without that in place pharmaceutical manufacturers lose control over their goods as it moves up in the supply chain.

Besides that, increasing pharmaceutical mandates and globalization is causing many pharma manufacturers to implement more strict protocols to stay ahead of the regulation. For instance, in European Union, almost 80% of pharma products need temperature-controlled transportation.

Furthermore, the COVID-19 pandemic has put a spotlight on the cold chain’s role in the pharmaceutical industry. With temperature-controlled vaccines for the virus, there is a need for optimizing the entire supply chain for the industry.

Traceability across the supply network

To ensure product quality there is a need for a system to track unit-level items, identifying issues, finding an optimized solution, communicate an action plan, and compose a response. Supply networks function based on the trading relationships between manufacturers, producers, retailers, suppliers, distributors, and consumers. Full traceability across the supply network that includes visibility across final products, raw materials, and intermediaries across trading partners and to the end consumer.

Monitoring

The companies that outsource logistics, their carriers and providers become an important part of the process with a high level of risk. To avoid the risk, recordable devices such as RFID tags and sensor technologies can enable companies to manage and monitor supply chains.

Digitization and Visibility

Most of the pharma companies are now working towards digitization. The main objective is visibility on demand into each business process right from production to sale. By digitizing the entire supply chain process pharma companies get better control and coordination and they can base their decisions on reliable data and information. The use of technologies such as IoT to collect real-time and relevant data and cloud platforms- to manage the data and make sense of it for your business needs and supply chain.

The demand for visibility across the supply chain due to increase in globalization that includes temperature monitoring and location irrespective of where in the world product is moving, is driving the technology market to create solutions to deliver and track data in real–time.

Final Word

To meet the varying demands and not to mess up an already complex process, the cold chain logistics in the pharmaceutical industry needs to be based on three points- service, agility, and cost-effectiveness.

Furthermore, with the expanding reach of the pharmaceutical cold chain sector the logistic providers, manufacturers, and carriers will need to continue to coordinate their efforts to address the ongoing cold chain challenges in the pharmaceutical industry.

The post Optimizing Supply Chain to Address Cold Chain Challenges in the Pharmaceutical Industry appeared first on ScaleUp Consulting..

The healthcare system consists of multiple arduous tasks that need substantial resource allocation, leading to increasing operations costs and slow processes. Leveraging the power of Robotic Process Automation (RPA), the healthcare industry can address many issues and make the entire system more efficient while improving patient satisfaction.

What is Robotic Process Automation?

Robotic Process Automation is a kind of automation technology that allows organizations to integrate and emulate human interactions within digital systems for more efficient business processes. Organizations can automate their processes at a fraction of the cost and time with RPA.

It is a non-intrusive technology and uses organizations’ existing infrastructure without disturbing its essential systems. Leveraging this technology in the healthcare sector presents opportunities to enhance healthcare delivery and free up clinician’s time.

Why is RPA important for the healthcare sector?

Robotic Process Automation can help reduce healthcare sector inefficiencies and contribute to better healthcare delivery, which is vital for both the public and the industry.

Like every other industry, the healthcare sector also has challenges such as strict regulations regarding patient data and fewer resources to deal with such regulations. With RPA enabled processes, healthcare providers can avoid long-running and costly digital transformation implementation projects and reap the rewards faster, thus enabling them to channel more resources to the healthcare industry.

RPA offers many benefits to the healthcare industry-

With robotic processes, patients can schedule their appointments without intervention from medical staff in clinics/hospitals. Therefore, eliminating the need for resource allocation for appointment scheduling enhances customer experience since patients can schedule appointments faster.
Another area where RPA is beneficial for the healthcare system is in managing the claim management process. Once healthcare service is delivered, the billing process typically takes time due to repetitive and manual claims management processes. With RPA enabled claim management, human errors can be avoided, and processing can be much faster.

In addition, RPA bots can streamline the process of front-office support, thus making it easy for the support staff to manage patient queries. Furthermore, RPA allows healthcare providers to document and track each step in the process in a structured format, thus enabling the organization to be audit compliant.

Moreover, RPA in the healthcare sector can help staff optimization since robots will complete all mundane tasks, thus giving employees more time to manage the strategic tasks.

Allowing robotic technology to handle business processes will improve clinical workflows and save time and enable tailored treatment for patients.
How can RPA strengthen the healthcare sector supply chain management?

In the quest to create a patient-centric and resilient supply chain, the healthcare industry is now turning to digital supply chain management. The digital supply chain networks not only provide better visibility across the end-to-end supply chain but enable members to share and access a continuous flow of actionable insights and information that can be used to improve supply chain processes continually.

The supply chain network ensures that patients, pharmacies, and healthcare providers get the medical supplies and medicines efficiently. RPA enabled processes can help in augmenting manufacturing and logistics processes.

The healthcare supply chain network has been continually fronting disruptions such as global health crisis, new regulatory mandates, and natural disasters. The ongoing pandemic challenged the resiliency of the healthcare supply chain. Now, many organizations are taking steps to shore up their supply chain, and one such step has been increasing the adoption of RPA.

The introduction of RPA in the healthcare supply chain can help improve resiliency by ensuring better controls and compliance, increasing process efficiencies, improving quality and much more. By leveraging RPA, the healthcare industry can streamline its key administrative functions such as order set up and entry, purchase order management, inventory management, and supply & demand planning.
It can help supply chain managers to track the inventory required in hospitals, such as syringes, needles, gloves, medicines, etc., by notifying them about the changes in demand and supply.

Final Word

Robotic Process Automation is a new technology with growing capabilities, and it not only automates the process but also increases accuracy. Robotic Process Automation can lead conversations, keep chaotic data structured, and make complex decisions.

The healthcare industry stands to gain from investing in Robotic Process Automation as it can result in improved patient care at less cost.

The post Robotic Process Automation In Healthcare Industry appeared first on ScaleUp Consulting..